AbbVie has filed for approval of a regimen based on its Venclexta therapy for previously untreated patients with chronic lymphocytic leukaemia (CLL), in combination with an AstraZeneca drug. The ...
President Donald Trump’s approval rating slipped to 37% according to a new poll released on Monday, a new low for his second term but still barely higher than his lowest approval ratings during his ...
President Donald Trump’s approval rating hit a new low point for his second term in the latest survey released Wednesday—hours after he claimed he has the “highest numbers I ever had.” President ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback